Navigation Links
New peritoneal dialysis diagnostic discovered
Date:10/17/2007

London, ON Thanks to a discovery by scientists at Robarts Research Institute and The University of Western Ontario, patients undergoing peritoneal dialysis may soon be able to worry less about the risks of infection and lessen their hospital stays.

Peritoneal dialysis, which involves placing a tube into the peritoneal cavity, allows people who have suffered from kidney failure to carry on a relatively normal life; however, complications include high incidence of infection of the abdominal cavity, known as peritonitis, which most patients experience every year or so.

Led by Joaquin Madrenas, Robarts scientist and Canada Research Chair in Immunobiology at Western, the study has looked at the molecule RIP2 (receptor-interacting protein 2) for clues over the past three years. Though the precise function of RIP2 is not yet known, scientists made the important finding that levels of the molecule increase during infection. More importantly, peritoneal dialysis patients with peritonitis who have high levels of RIP2 can be sent home and treated with antibiotics. If RIP2 levels do not go up, patients risk a protracted infection and should be admitted for closer monitoring and more intense treatment. This information can be used to address the need to admit patients to the hospital.

We currently have no objective indicator if peritonitis will be really bad, so we tend to try to guess how bad it is, says Madrenas. What we have found is that, by monitoring RIP2, we can predict the outcome of the infection in patients taking part in peritoneal dialysis.

By keeping patients out of hospitals, this discovery not only helps improve quality of life, but also reduces strain on the healthcare system.

The team, which includes Madrenas PhD student Michelle McCully and a close collaboration with Dr. Peter Blake of the division of nephrology at Western, will now try to adapt the discovery to a clinical laboratory and hopefully develop a diagnostic test that can be conducted with a patients peritoneal fluid on a routine basis. Madrenas also wonders if there are other factors preventing RIP2 levels from increasing in some patients. If we know what problem is preventing this increase, we could fix it and possibly prevent infections, he says.


'/>"/>

Contact: Ann Hutchison
ahutch2@uwo.ca
51-966-121-118-5468
University of Western Ontario
Source:Eurekalert

Related medicine news :

1. Death Risk Of Ovarian Cancer Reduced By Intraperitoneal Chemotherapy
2. Recognizing heart risk in dialysis patients
3. Easier Dialysis for Kids
4. More Patients Going In For Home Dialysis
5. Dialysis Clinics Owned By Fresenius Flourishes Due To Its Customers
6. SRN Hospital Dialysis Unit To Resume Function
7. Heparin Based Nanoscale Materials Developed For Dialysis Treatment
8. Exercise Combined with Dialysis Yields Better Results
9. Surveillance Program for Haemodialysis Reduces Infection
10. Vitamin E-Coated Dialysis Filters Help Fight Anemia in Hemodialysis Patients
11. Dialysis Patients With Metabolic Syndrome Show Increased Risk for Heart Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief ... a minimum wage raise to $12 an hour by 2020 and then adjusting it yearly ... lost value of the minimum wage, assure the wage floor does not erode again, and ...
(Date:6/24/2016)... Georgia (PRWEB) , ... June 24, 2016 , ... ... awards today at the Clinical Decision Making in Emergency Medicine conference in Ponte ... have authored journal articles published in Emergency Medicine Practice and Pediatric ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Investment Group (TGIG), has initiated cultivation and processing operations at its production facility, ... Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of proactive ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone Partners ... extensive sequencing and genomics experience, as Vice President of North American Capital Sales at ... responsible for leading the sales team in the commercialization of the HTG EdgeSeq system ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... human induced pluripotent stem (iPS) cells and other difficult to transfect cells, announces ... Medium. The PluriQ™ G9™ Gene Editing System is a complete system ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... 2022" report to their offering. ... with kidney failure, it replaces the function of kidneys by ... and thus the treatment helps to keep the patient body,s ... Increasing number of ESRD patients & substantial healthcare ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
Breaking Medicine Technology: